LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex
Authors:
Mi S, Lee X, Shao Z, Thill G, Ji B, Relton J, Levesque M, Allaire N, Perrin S, Sands B, Crowell T, Cate RL, McCoy JM and Pepinsky RB
In:
Source:
Nat Neurosci
Publication Date:
(
2004
)
Issue:
7(3)
:
221-8
Research Area:
Neurobiology
Cells used in publication:
Neuron, hippo/cortical, rat
Species: rat
Tissue Origin: brain
Experiment
Primary P7 rat culture cerebellar granular neurons were nucleofected with the dominant negative form DN-LINGO-1, lacking the cytoplasmic domain involved in binding the Nogo-66 receptor /p75 signaling complex. DN-LINGO-1 transfected neurons built longer axons due to a diminished responsiveness to myelin inhibition. In the absence of myelin, no axon outgrowth could be observed. The cells also showed a decreased level of RhoA activation.
Abstract
Axon regeneration in the adult CNS is prevented by inhibitors in myelin. These inhibitors seem to modulate RhoA activity by binding to a receptor complex comprising a ligand-binding subunit (the Nogo-66 receptor NgR1) and a signal transducing subunit (the neurotrophin receptor p75). However, in reconstituted non-neuronal systems, NgR1 and p75 together are unable to activate RhoA, suggesting that additional components of the receptor may exist. Here we describe LINGO-1, a nervous system-specific transmembrane protein that binds NgR1 and p75 and that is an additional functional component of the NgR1/p75 signaling complex. In non-neuronal cells, coexpression of human NgR1, p75 and LINGO-1 conferred responsiveness to oligodendrocyte myelin glycoprotein, as measured by RhoA activation. A dominant-negative human LINGO-1 construct attenuated myelin inhibition in transfected primary neuronal cultures. This effect on neurons was mimicked using an exogenously added human LINGO-1-Fc fusion protein. Together these observations suggest that LINGO-1 has an important role in CNS biology.
Open in PubMed